ArticleHead & face medicine2026
Understanding the risk of metastasis in lower lip carcinoma: clinical insights and prognostic implications.
Article in Head & face medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundsCutaneous squamous cell carcinoma accounts for the second most skin tumor and is mostly found in the head and neck area. Lymph nodal spreading appears in around 5% of all patients and worsens the prognosis as well as overall survival. Especially the tumor localisation in the lower lip is known for a higher risk of lymph nodal metastases.
methodsData of 71 patients suffering from cutaneous squamous cell carcinoma (CSCC) of the lower lip were analyzed retrospectively. Risk factors such as tumor size and depth of invasion and other histopathological findings were collected. Logistic regression analysis was performed to determine the value of different risk factors.
resultsOne-third of all patients suffered from lymph nodal metastases. Poor differentiation was the strongest risk factor for lymph nodal spreading. Tumor diameter of more than 1.6 cm and depth of invasion greater than 0.85 cm were also considered as factors. Patients with G3 tumors had a 19.1 times higher risk for lymph nodal spreading.
conclusionThe lower lip location has a high risk for lymph node metastasis in CSCC. Overall, poor differentiation was the strongest factor associated with an increased risk of lymph node metastases in this patient cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.